लेवोथायरोक्सिन और लियोथायरोनिन और पियोग्लिटाज़ोन और ग्लिमेपिराइड का इंटरैक्शन

Insulin or Oral Hypoglycemics — Initiating thyroid replacement therapy may cause increases in insulin or oral hypoglycemic requirements.

Patients receiving insulin or oral hypoglycemics should be closely watched during initiation of thyroid replacement therapy.

…somatropin, protease inhibitors, atypical antipsychotic medications (e.g., olanzapine and clozapine), barbiturates, diazoxide, laxatives, rifampin, thiazides and other diuretics, corticosteroids, phenothiazines, thyroid hormones, estrogens, oral contraceptives, phenytoin, nicotinic acid, sympathomimetics (e.g., epinephrine, albuterol, terbutaline), and isoniazid.